annual CFF:
$361.14M+$2.51B(+116.81%)Summary
- As of today (May 21, 2025), RPRX annual cash flow from financing activities is $361.14 million, with the most recent change of +$2.51 billion (+116.81%) on December 31, 2024.
- During the last 3 years, RPRX annual CFF has fallen by -$23.97 million (-6.22%).
- RPRX annual CFF is now -75.72% below its all-time high of $1.49 billion, reached on December 31, 2020.
Performance
RPRX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$941.30M-$683.34M(-264.90%)Summary
- As of today (May 21, 2025), RPRX quarterly cash flow from financing activities is -$941.30 million, with the most recent change of -$683.34 million (-264.90%) on March 31, 2025.
- Over the past year, RPRX quarterly CFF has dropped by -$729.30 million (-344.01%).
- RPRX quarterly CFF is now -159.60% below its all-time high of $1.58 billion, reached on June 30, 2020.
Performance
RPRX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$368.16M-$729.30M(-201.94%)Summary
- As of today (May 21, 2025), RPRX TTM cash flow from financing activities is -$368.16 million, with the most recent change of -$729.30 million (-201.94%) on March 31, 2025.
- Over the past year, RPRX TTM CFF has increased by +$1.78 billion (+82.88%).
- RPRX TTM CFF is now -123.67% below its all-time high of $1.56 billion, reached on June 30, 2020.
Performance
RPRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RPRX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +116.8% | -344.0% | +82.9% |
| 3 y3 years | -6.2% | -326.0% | -194.2% |
| 5 y5 years | +130.3% | -273.5% | -10.2% |
RPRX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.2% | +116.8% | -181.4% | +30.8% | -194.2% | +83.1% |
| 5 y | 5-year | -75.7% | +116.8% | -159.6% | +30.8% | -123.7% | +83.1% |
| alltime | all time | -75.7% | +116.8% | -159.6% | +30.8% | -123.7% | +83.1% |
RPRX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$941.30M(+264.9%) | -$368.16M(-201.9%) |
| Dec 2024 | $361.14M(-116.8%) | -$257.96M(-20.7%) | $361.14M(-6.7%) |
| Sep 2024 | - | -$325.50M(-128.1%) | $387.21M(-159.9%) |
| Jun 2024 | - | $1.16B(-645.6%) | -$646.77M(-69.9%) |
| Mar 2024 | - | -$212.00M(-8.6%) | -$2.15B(+0.1%) |
| Dec 2023 | -$2.15B(+127.4%) | -$231.89M(-82.9%) | -$2.15B(-1.5%) |
| Sep 2023 | - | -$1.36B(+291.8%) | -$2.18B(+107.3%) |
| Jun 2023 | - | -$347.00M(+64.9%) | -$1.05B(+12.7%) |
| Mar 2023 | - | -$210.37M(-20.8%) | -$934.26M(-1.1%) |
| Dec 2022 | -$944.86M(-345.3%) | -$265.55M(+15.4%) | -$944.86M(+7.7%) |
| Sep 2022 | - | -$230.09M(+0.8%) | -$877.38M(-326.7%) |
| Jun 2022 | - | -$228.25M(+3.3%) | $386.98M(-1.0%) |
| Mar 2022 | - | -$220.97M(+11.6%) | $390.82M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $385.11M(-74.1%) | -$198.07M(-119.2%) | $385.11M(+25.9%) |
| Sep 2021 | - | $1.03B(-560.9%) | $305.79M(-128.2%) |
| Jun 2021 | - | -$224.41M(-1.0%) | -$1.09B(-251.2%) |
| Mar 2021 | - | -$226.67M(-18.3%) | $717.98M(-51.7%) |
| Dec 2020 | $1.49B(-224.8%) | -$277.39M(-22.4%) | $1.49B(+0.6%) |
| Sep 2020 | - | -$357.39M(-122.6%) | $1.48B(-4.9%) |
| Jun 2020 | - | $1.58B(+191.1%) | $1.56B(-565.5%) |
| Mar 2020 | - | $542.52M(-289.8%) | -$334.15M(-72.0%) |
| Dec 2019 | -$1.19B(-13.6%) | -$285.80M(+1.8%) | -$1.19B(+31.6%) |
| Sep 2019 | - | -$280.69M(-9.5%) | -$905.82M(+44.9%) |
| Jun 2019 | - | -$310.18M(-1.5%) | -$625.13M(+98.5%) |
| Mar 2019 | - | -$314.96M | -$314.96M |
| Dec 2018 | -$1.38B(+1018.9%) | - | - |
| Dec 2017 | -$123.25M | - | - |
FAQ
- What is Royalty Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Royalty Pharma?
- What is Royalty Pharma annual CFF year-on-year change?
- What is Royalty Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Royalty Pharma?
- What is Royalty Pharma quarterly CFF year-on-year change?
- What is Royalty Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Royalty Pharma?
- What is Royalty Pharma TTM CFF year-on-year change?
What is Royalty Pharma annual cash flow from financing activities?
The current annual CFF of RPRX is $361.14M
What is the all time high annual CFF for Royalty Pharma?
Royalty Pharma all-time high annual cash flow from financing activities is $1.49B
What is Royalty Pharma annual CFF year-on-year change?
Over the past year, RPRX annual cash flow from financing activities has changed by +$2.51B (+116.81%)
What is Royalty Pharma quarterly cash flow from financing activities?
The current quarterly CFF of RPRX is -$941.30M
What is the all time high quarterly CFF for Royalty Pharma?
Royalty Pharma all-time high quarterly cash flow from financing activities is $1.58B
What is Royalty Pharma quarterly CFF year-on-year change?
Over the past year, RPRX quarterly cash flow from financing activities has changed by -$729.30M (-344.01%)
What is Royalty Pharma TTM cash flow from financing activities?
The current TTM CFF of RPRX is -$368.16M
What is the all time high TTM CFF for Royalty Pharma?
Royalty Pharma all-time high TTM cash flow from financing activities is $1.56B
What is Royalty Pharma TTM CFF year-on-year change?
Over the past year, RPRX TTM cash flow from financing activities has changed by +$1.78B (+82.88%)